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• Furosemide, a loop diuretic, is practically insoluble in water (0.01825 mg/mL) and is degraded by light 1,2 .
• The bioavailability of orally administered • The bioavailability of orally administered furosemide in conventional dosage forms is poor and highly variable, and associated with low aqueous solubility, site-specific drug absorption, and first-pass metabolism 3 .
• Some studies showed that inhalation of furosemide alleviates dyspnoea by modulating vagal afferent activity in animal lung models 4 and reduces the intensity of induced dyspnoea in healthy individuals 5 .
• Further studies suggested that nebulised furosemide might be effective against dyspnoea of asthma 6 and might be effective against dyspnoea of asthma 6 and lung cancer 7 .
• β-cyclodextrin (β-CD) is a natural cyclic oligosaccharide and several studies have reported a positive effect of CD complexation on the physicochemical characteristics of many hydrophobic drugs 8 .
• The ring has a hydrophilic exterior and lipophilic core in which appropriately sized organic molecules can form non-covalent inclusion complexes.
• Complexation relies on relatively weak force such as London forces, hydrogen bonding and hydrophobic interactions.
• Inclusion complexation with agents such as β-cyclodextrin (β-CD) is one method to increase the aqueous solubility of a poorly water-soluble drug and thereby its stability and bioavailability 9 .
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Nebulisation was continued for 20 min until the nebulisation chamber was empty.
All drugs were dissolved in 4 mL normal saline before use in the nebulisation chamber.
Pulmonary function was assessed by measuring:
(FEV1) forced expiratory volume in 1 s; (FVC) forced vital capacity; (PFER) peak expiratory flow rate; (RR) respiratory rate; (SaO 2 ) arterial oxygen saturation in each patient before and 30 min after medication. Complexes of furosemide and CD improve FEV1, FVC, peak flow rate, SaO 2 and clinical scores significantly as compared to salbutamol or furosemide alone. The complex effect was nearly equal to the effect of the furosemide nearly equal to the effect of the furosemide and salbutamol combination.
These results suggest that CDs are promising solubility enhancers for improving the efficacy of poorly water soluble drugs administered by inhalation.
